Beauty Health (SKIN) to Release Earnings on Thursday

Beauty Health (NASDAQ:SKIN) will likely be posting its Q1 2026 results after the market closes on Thursday, May 7th. Analysts expect the company to announce earnings of ($0.09) per share and revenue of $66.2780 million for the quarter. Investors may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Thursday, May 7, 2026 at 4:30 PM ET.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings results on Thursday, March 12th. The company reported ($0.06) EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. The company had revenue of $82.37 million for the quarter, compared to analyst estimates of $78.07 million. Beauty Health had a negative net margin of 3.16% and a negative return on equity of 15.40%. On average, analysts expect Beauty Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Beauty Health Stock Performance

Shares of NASDAQ:SKIN traded up $0.02 during midday trading on Tuesday, hitting $0.92. The company’s stock had a trading volume of 314,580 shares, compared to its average volume of 649,151. Beauty Health has a fifty-two week low of $0.76 and a fifty-two week high of $2.69. The company has a debt-to-equity ratio of 3.94, a quick ratio of 1.40 and a current ratio of 1.66. The stock has a market capitalization of $116.91 million, a price-to-earnings ratio of -4.57 and a beta of 1.12. The stock’s 50 day simple moving average is $0.98 and its 200 day simple moving average is $1.25.

Analyst Ratings Changes

Several analysts have recently issued reports on the company. Jefferies Financial Group reissued a “hold” rating and set a $1.60 target price on shares of Beauty Health in a report on Wednesday, January 14th. Zacks Research upgraded shares of Beauty Health from a “strong sell” rating to a “hold” rating in a research report on Monday, March 16th. TD Cowen reduced their price target on shares of Beauty Health from $1.65 to $1.50 and set a “hold” rating for the company in a report on Monday, March 16th. Canaccord Genuity Group dropped their price target on Beauty Health from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Friday. Finally, Benchmark restated a “hold” rating on shares of Beauty Health in a report on Friday, March 13th. One research analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $2.32.

Institutional Investors Weigh In On Beauty Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Invesco Ltd. increased its stake in Beauty Health by 65.4% during the 4th quarter. Invesco Ltd. now owns 69,422 shares of the company’s stock worth $96,000 after buying an additional 27,453 shares during the period. Millennium Management LLC grew its stake in Beauty Health by 127.0% during the fourth quarter. Millennium Management LLC now owns 5,764,802 shares of the company’s stock worth $8,013,000 after buying an additional 3,225,668 shares during the period. AQR Capital Management LLC increased its holdings in Beauty Health by 270.1% in the 4th quarter. AQR Capital Management LLC now owns 333,196 shares of the company’s stock valued at $463,000 after purchasing an additional 243,179 shares in the last quarter. Atom Investors LP purchased a new stake in shares of Beauty Health in the fourth quarter worth about $29,000. Finally, Squarepoint Ops LLC lifted its position in Beauty Health by 22.6% during the 4th quarter. Squarepoint Ops LLC now owns 275,885 shares of the company’s stock worth $383,000 after acquiring an additional 50,794 shares in the last quarter. 93.26% of the stock is owned by institutional investors and hedge funds.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.